The caries vaccine: a growing prospect.
A vaccine against dental caries, for so long a subject of purely academic research, is currently undergoing phase II clinical trials and could be available commercially within 5 to 6 years. The approach, which is safe, effective, and provides long-term protection for up to a year, is based on a topical application and does not require any injections. The development of this vaccine has been made possible by recent advances in molecular biology and genetic engineering. Perhaps one of the most intriguing aspects has been the use of green plants to produce the vaccine. This article describes a topical vaccine against Streptococcus mutans, which is the main cause of dental caries.
Ma
J K
JK
Department of Oral Medicine and Pathology, Guy's Hospital, London.
D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001428:Bacterial Vaccines; D003731:Dental Caries / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000096:biosynthesis; D030821:Plants, Genetically Modified; D013295:Streptococcus mutans / Q000276:immunology* / Q000472:pathogenicity
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D007074:Immunoglobulin G